Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Sheehy

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 29, 2019
Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancyAnick Bérard, Odile Sheehy, Jin-Ping Zhao, et al.
Current Drug Safety|August 4, 2016
Ovarian Stimulation, Intrauterine Insemination, Multiple Pregnancy and Major Congenital Malformations: A Systematic Review and Meta- Analysis- The ART_Rev StudySonia Chaabane, Odile Sheehy, Patricia Monnier, et al.
Frontiers in Pharmacology|August 4, 2017
Association between <i>CYP2D6</i> Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during PregnancyAnick Bérard, Andrea Gaedigk, Odile Sheehy, et al.
Annals of Neurology|November 28, 2025
Late Pregnancy Antiseizure Medication Exposure and Offspring Neurodevelopmental Risk: A Multi-Child Cohort StudyOdile Sheehy, Vanina Tchuente, Sherif Eltonsy, et al.
Archives of Women'S Mental Health|March 10, 2016
Impact of maternal prenatal and parental postnatal stress on 1-year-old child development: results from the OTIS antidepressants in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Psychological Assessment|May 5, 2015
The ASQ and R-PDQ telephone-administered validation within the OTIS antidepressant in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Research in Nursing & Health|April 19, 2012
Reliability and validity of the 4-item perceived stress scale among pregnant women: results from the OTIS antidepressants studyFatiha Karam, Anick Bérard, Odile Sheehy, et al.
Frontiers in Pharmacology|November 27, 2024
Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO)Payam Peymani, Anick Berard, Brandace Winquist, et al.
Plos One|September 20, 2022
The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and AlbertaAnick Bérard, Padma Kaul, Sherif Eltonsy, et al.
Pharmacoepidemiology and Drug Safety|December 26, 2025
Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North AmericaOdette de Bruin, Emeline Maisonneuve, Eimir Hurley, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 29, 2019
Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancyAnick Bérard, Odile Sheehy, Jin-Ping Zhao, et al.
Current Drug Safety|August 4, 2016
Ovarian Stimulation, Intrauterine Insemination, Multiple Pregnancy and Major Congenital Malformations: A Systematic Review and Meta- Analysis- The ART_Rev StudySonia Chaabane, Odile Sheehy, Patricia Monnier, et al.
Frontiers in Pharmacology|August 4, 2017
Association between <i>CYP2D6</i> Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during PregnancyAnick Bérard, Andrea Gaedigk, Odile Sheehy, et al.
Annals of Neurology|November 28, 2025
Late Pregnancy Antiseizure Medication Exposure and Offspring Neurodevelopmental Risk: A Multi-Child Cohort StudyOdile Sheehy, Vanina Tchuente, Sherif Eltonsy, et al.
Archives of Women'S Mental Health|March 10, 2016
Impact of maternal prenatal and parental postnatal stress on 1-year-old child development: results from the OTIS antidepressants in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Psychological Assessment|May 5, 2015
The ASQ and R-PDQ telephone-administered validation within the OTIS antidepressant in pregnancy studyFatiha Karam, Odile Sheehy, Marie-Claude Huneau, et al.
Research in Nursing & Health|April 19, 2012
Reliability and validity of the 4-item perceived stress scale among pregnant women: results from the OTIS antidepressants studyFatiha Karam, Anick Bérard, Odile Sheehy, et al.
Frontiers in Pharmacology|November 27, 2024
Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO)Payam Peymani, Anick Berard, Brandace Winquist, et al.
Plos One|September 20, 2022
The Canadian Mother-Child Cohort Active Surveillance Initiative (CAMCCO): Comparisons between Quebec, Manitoba, Saskatchewan, and AlbertaAnick Bérard, Padma Kaul, Sherif Eltonsy, et al.
Pharmacoepidemiology and Drug Safety|December 26, 2025
Medications Used Among Nonhospitalized Pregnant Women With COVID-19: A Prospective Individual Patient Data Meta-Analysis in Europe and North AmericaOdette de Bruin, Emeline Maisonneuve, Eimir Hurley, et al.
Pageof 8